The data from this study demonstrate that serum ENOX2 proteins characteristic of malignant mesothelioma can be detected in subjects 4–11 years before diagnosis based on clinical symptoms, and raises the possibility that the benefits of early intervention could be studied in such individuals. This evidence concerns the gene ENOX2 and malignant mesothelioma.